NEWS
Benzinga I EXCLUSIVE: Tonix Pharmaceuticals CEO Highlights Advantages Of Company’s Monkeypox Vaccine In Development

Tonix Pharmaceuticals Holding Corp shares are soaring Monday after the World Health Organization (WHO) declared monkeypox a public health emergency of global concern. Tonix’s TNX-801 is being developed as a vaccine to protect against monkeypox. “We already have very compelling data showing protection of monkeys against the lethal challenge of monkeypox,” Tonix CEO Seth Lederman said Monday on Benzinga’s YouTube show […]

Clinical Trials Arena I Aristea contemplates Phase III design for rare skin disease drug

With a Phase IIb palmoplantar pustulosis (PPP) trial underway, Aristea Therapeutics is looking ahead to a potential Phase III study. But different primary endpoint preferences between regulators in the US and Europe could complicate its trial design process. Aristea is testing its small molecule RIST4721 in an ongoing 156-patient Phase IIb trial in PPP (NCT05194839), […]

Parkinson’s News Today I FDA Gives Green Light to Phase 3 Trial of Buntanetap

Annovis Bio has been given the go-ahead by the U.S. Food and Drug Administration (FDA) to begin a Phase 3 clinical trial to test buntanetap (ANVS401) as an oral therapy for early-stage Parkinson’s disease. “With this FDA notice in hand, we are thrilled to start recruiting for the US clinical trial soon, expected later this summer,” Maria […]